Farag Kameel D. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Farag Kameel D.（CIK 2093620）在 1 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-08-19）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-19 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 1,728 | $12,995 |
| 2026-08-05 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 1,130 | $12,995 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 1,248 | $12,505 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 1,395 | $13,001 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 1,570 | $13,000 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 2,539 | $13,000 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 3,725 | $13,000 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 7,353 | $27,500 |
| 2026-06-25 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 1,000 | $13,000 |
| 2025-11-04 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 32,000 | $24,000 |
| 2025-11-04 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 26,619 | $19,964 |
| 2025-10-24 | Akari Therapeutics Plc (AKTX) | Interim CFO | 买入 | 6,277 | $4,645 |
来源：SEC Form 4 申报文件 · 截至 2026-08-19